Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Библиографические подробности
Главный автор:	Shobnam, Sohana
Другие авторы:	Azam, Faruque
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2024
Предметы:	Phase II trials Breast cancer Efficacy endpoints Progression-free survival Breast Cancer. Breast Cancer > Survival.
Online-ссылка:	http://hdl.handle.net/10361/24396

Схожие документы

Breast cancer awareness seminars
по: Anwer Khan Modern Medical College
Опубликовано: (2016)

Recent advancement on breast cancer detection and treatment
по: Rahman, Sanjida
Опубликовано: (2023)

Natural products and their combinatory effects in breast cancer treatment
по: Siddique, Md. Ayman
Опубликовано: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
по: Alam, Kazi Tasnuva
Опубликовано: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
по: Raihan, Dilraj
Опубликовано: (2024)

The impact of breast cancer on women’s lives in Bangladesh
по: Mobashera, Tayeeba Tum
Опубликовано: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
по: Akter, Honufa
Опубликовано: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
по: Chakraborty, Anuradha
Опубликовано: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
по: Iqbal, Mohammad Shamim, и др.
Опубликовано: (2017)

A review on triple-negative breast cancer and its potential treatment
по: Niasa, Jannatul Ferdous
Опубликовано: (2023)

Machine learning as an indicator for breast cancer prediction
по: Shadman, Tahsin Mohammed, и др.
Опубликовано: (2019)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
по: Araf, Faiaz Fahim
Опубликовано: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
по: Rahman, Tasnim
Опубликовано: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
по: Paul, Pulock
Опубликовано: (2024)

Breast cancer therapy through Liposomal drug delivery system
по: Ome, Nusrat Jahan
Опубликовано: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
по: Lamia
Опубликовано: (2020)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
по: Nuha, Nabiha Tahsin
Опубликовано: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
по: Oishy, Jannatun Noor
Опубликовано: (2024)

Early detection of breast cancer using machine learning
по: Fuad, Wasi Mohammad
Опубликовано: (2019)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
по: Mirza, Maisa Tasnim
Опубликовано: (2023)

Breast cancer in South Asia: a Bangladeshi perspective
по: Hossain, Mohammad Sorowar, и др.
Опубликовано: (2017)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
по: Hasan, Sakib
Опубликовано: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
по: Parvin, Salma, и др.
Опубликовано: (2016)

Breast cancer prediction using different machine learning models
по: Khandker Al- Muhaimin, и др.
Опубликовано: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
по: Hasan, Amit
Опубликовано: (2024)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
по: Sakib, Hasibul, и др.
Опубликовано: (2024)

Machine learning In breast cancer prognosis and prediction
по: Chowdhury, Shah Abul Hasnat, и др.
Опубликовано: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Karim, Samia Binte
Опубликовано: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
по: Monayem, Kazi Fahim
Опубликовано: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
по: Hoque, Ismoth Ara
Опубликовано: (2024)

Statistics and informatics in molecular cancer research

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
по: Karim, Azrin
Опубликовано: (2024)

Application of deep convolutional neural network in breast cancer prediction using Digital Mammograms
по: Al Mamun, Rafsan, и др.
Опубликовано: (2022)

Best feature selection and data visualization for breast cancer prediction
по: Hemel, Tanjim Ahmed, и др.
Опубликовано: (2020)

Cancer risk factors: a critical review
по: Tabassum, Tahsina
Опубликовано: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
по: Nawar, Anika
Опубликовано: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
по: Abir, Shifaty Nur
Опубликовано: (2024)

Targeting BRAFV600E in the treatment of CRC
по: Roja, Mashwiyat Samrin
Опубликовано: (2024)

Role of statins as antagonists of SPARC in gastric cancer
по: Shahmat, Rad
Опубликовано: (2019)